Umeclidinium and Trospium / Xanomeline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Umeclidinium
No brand names on recordTrospium / Xanomeline
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines work in a similar way, by blocking a body chemical called acetylcholine. Umeclidinium is an inhaled medicine that helps open your airways, and trospium/xanomeline (Cobenfy) also has this blocking action. When you take two drugs with this same effect, the side effects can add up.
That means you might notice more dry mouth, constipation, blurry vision, or trouble emptying your bladder. This is expected in theory rather than proven, and it is usually manageable. The good news is your care team can keep an eye on things and adjust as needed, so let your pharmacist or doctor know if these symptoms bother you.
Mechanism: Additive antimuscarinic (anticholinergic) pharmacodynamic effect. Umeclidinium is a long-acting muscarinic antagonist (LAMA); trospium is an antimuscarinic and the trospium/xanomeline combination carries anticholinergic activity. Neither is a relevant prodrug here; this is a PD, not PK, interaction.
- Direction: Increased cumulative antimuscarinic burden.
- Effect: Higher frequency/severity of dry mouth, constipation, urinary retention, blurred vision, tachycardia.
- Onset: Unspecified.
- Evidence: Theoretical; severity moderate.
- Management: Monitor for anticholinergic adverse reactions; dose/therapy may be individualized by the care team.
What happens
An increased risk of anticholinergic adverse reactions (eg, dry mouth, constipation)
Interaction Deep Dive
When trospium/xanomeline is taken alongside antimuscarinic agents that cause anticholinergic side effects (for example, dry mouth and constipation), the incidence and/or intensity of these effects may rise. Should these drugs be given together, watch patients for a heightened frequency and/or severity of anticholinergic adverse reactions1.
Why it happens (mechanism)
Additive antimuscarinic effects
How to manage this interaction
If you have been prescribed both, keep taking them as directed unless your prescriber tells you otherwise. The main step here is watching for added-up anticholinergic side effects.
- Watch for: dry mouth, constipation, blurry vision, difficulty urinating, or a faster heartbeat.
- Report symptoms to your pharmacist or prescriber if they appear or worsen.
- Your care team may monitor you more closely and can adjust or individualize your therapy if needed.
- Simple comfort measures (sipping water, fiber, staying hydrated) can help with dry mouth or constipation.
Do not start or stop either medicine on your own.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Umeclidinium and Trospium / Xanomeline together?
Taking umeclidinium with trospium/xanomeline can add up their anticholinergic effects, so watch for more dry mouth, constipation, or urinary trouble and tell your pharmacist or doctor if they occur. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Umeclidinium and Trospium / Xanomeline interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Umeclidinium and Trospium / Xanomeline interaction managed?
If you have been prescribed both, keep taking them as directed unless your prescriber tells you otherwise. The main step here is watching for added-up anticholinergic side effects. Watch for: dry mouth, constipation, blurry vision, difficulty urinating, or a faster heartbeat. Report symptoms to your pharmacist or prescriber if they appear or worsen. Your care team may monitor you more closely and… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Umeclidinium or Trospium / Xanomeline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Citation #1
Keep reading about Umeclidinium
Keep reading about Trospium / Xanomeline
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist